Company intelligence / Profile preview

Alaven Pharmaceutical

Marietta, Georgia, United Statesbionity.com ↗

Ownership: Private
Employees: ~180
Development stage: Other

Overview

Alaven Pharmaceutical was a US-based specialty pharmaceutical company focused on prescription and non-prescription products for women’s health and gastroenterology. Its portfolio included several well-known brands such as Proctofoam, Cortifoam, Epifoam, Levsin, Rowasa, TriLyte, and Prefera prenatal vitamins. The company demonstrated steady sales growth through strategic asset acquisitions and product line extensions. In October 2010 it was acquired by Meda AB for $350 million to strengthen Meda’s US presence in gastroenterology and women’s health.

Therapeutic areas: GastroenterologyWomen's Health
Modalities: Small moleculeBiologicHormoneVitamin/mineral supplement
Industry: Biotech

Beyond the preview

Go deeper on Alaven Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alaven Pharmaceutical.

Explore the full profile